Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”
In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.
NIH Authorization Bills Require NCI To Spend 10% On Cancer control
NCAB Urges $2 Tax On Cigarettes To Reduce Smoking
NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues
Pryor Calls For Price Regulation Of Drugs In Health Reform
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
